AstraZeneca admitted in High Court of London, United Kingdom, that its vaccine had the potential to cause thrombosis with thrombocytopenia syndrome
AstraZeneca admitted in High Court of London, United Kingdom, that its vaccine had the potential to cause thrombosis with thrombocytopenia syndrome